Target intelligence / Profile preview

Microtubule-associated protein tau (phosphorylated form) (Tau (pTau); MAPT (for gene))

Target
Tau (pTau); MAPT (for gene)
Molecular classification
Microtubule-associated protein, Intrinsically disordered protein, Post-translationally modified protein
01

Overview

Phosphorylated tau is the post-translationally modified form of microtubule-associated protein tau, primarily via phosphorylation at multiple serine, threonine, and tyrosine residues. Physiologically, tau stabilizes neuronal microtubules, enabling axonal transport and maintaining neuron structure. Tau is regulated by both kinases and phosphatases, with phosphorylation shifting its affinity and association with microtubules. Under pathological conditions (notably in Alzheimer's disease and other tauopathies), tau becomes abnormally hyperphosphorylated, leading to weakened microtubule stabilization, detachment from microtubules, mislocalization, and self-assembly into paired helical filaments and neurofibrillary tangles. These aggregated tau forms disrupt cellular transport, contribute to neuronal death, and serve as a pathological hallmark of several neurodegenerative diseases. Phosphorylated tau can also affect nuclear functions, including chromatin organization and DNA protection, and undergoes dynamic phase separation dependent on phosphorylation state. Targeting phosphorylated tau for therapy focuses on preventing its pathological aggregation, modulating phosphorylation via kinase/phosphatase regulators, and promoting clearance. Reliable detection of phosphorylated tau isoforms in CSF and imaging serves as a key biomarker for early diagnosis and disease monitoring. Safety remains a challenge due to tau’s numerous biological roles and the risk of disrupting normal neuronal function.

Other names
Phosphorylated taupTauMAPT (Microtubule-associated protein tau gene)Hyperphosphorylated tauNeurofibrillary tangle tau
02

Mechanism of action

Mechanism of action for drugs targeting phosphorylated tau include inhibition of tau phosphorylation (e.g., via kinase inhibitors), inhibition of tau aggregation/fibrillization, promotion of tau clearance, modulation of tau-mediated microtubule stabilization, and enhancement of O-GlcNAc modification to prevent hyperphosphorylation.

03

Biological functions

Microtubule stabilizationAxonal transportMaintenance of neuronal structureRegulation of chromatin and DNA protectionPhase separation within nucleusCell cycle regulationAggregate formation in disease states
04

Disease associations

Neurodegenerative disease (Alzheimer’s disease, frontotemporal dementia, progressive supranuclear palsy, other tauopathies)Mental retardation in MAPT microdeletion syndrome
05

Safety considerations

Off-target effects of kinase inhibitorsSelectivity in distinguishing pathological from physiological phosphorylationImpairment of normal tau functions leading to neuronal toxicity or dysfunctionCrossing the blood-brain barrierPotential for worsening cellular aggregation or toxicity
06

Interacting drugs

Methylthioninium chloride (Methylene blue)

4 more in the full profile.

07

Biomarkers

Phosphorylated tau species in cerebrospinal fluid (CSF) (e.g., pTau181, pTau217, pTau231)Neurofibrillary tangle burden via imaging or post-mortem histologyTau PET tracers for brain imaging

Beyond the preview

Go deeper on Microtubule-associated protein tau (phosphorylated form) (Tau (pTau); MAPT (for gene)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule-associated protein tau (phosphorylated form) (Tau (pTau); MAPT (for gene)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call